glutathione-s-transferases Glutathione S-transferases in kidney and urinary bladder tumors Frontiers | Glutathione S-Transferase Enzymes
Description
doi: 10.1016/j.jcf.2010.09.005 178 SaimanL.AnsteadM.Mayer-HamblettN.LandsL
Instead, some animal experiments and clinical trials have suggested that TZDs might improve ventricular structure or function
Bone Marrow Transplant (2005) 35(3):23341
The 2019 AASLD practice guidance and guidelines updated their recommended first-line treatment: either prednisone monotherapy (4060 mg/day) or a combination of prednisone (2040 mg/day) or budesonide (9 mg/day) and AZA (50100 mg/day) [96]
